Drug Type Small molecule drug |
Synonyms CLP-635, CLP-656 |
Target |
Action activators |
Mechanism KCC2 activators(solute carrier family 12 member 5 activators) |
Therapeutic Areas |
Active Indication- |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingDiscovery |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Epilepsy | Discovery | Canada | - | |
| Neuralgia | Discovery | Canada | - |





